Farmakemi B.V.

The drug is used in combination with other chemotherapeutic agents for the treatment of testicular cancer, small cell lung cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, acute myeloid leukemia, gestational trophoblastic neoplasia, as well as non-epithelial and platinum-resistant epithelial ovarian cancer.

Dosage form: concentrate for infusion solution

ATC: L01CB01

The drug is used for the chemotherapy of ovarian cancer, breast cancer, advanced non-small cell lung cancer, as well as for the treatment of Kaposi's sarcoma in patients with AIDS.

Dosage form: concentrate for infusion solution

ATC: L01CD01

The drug is used to treat non-Hodgkin lymphoma, Hodgkin's disease, disseminated testicular cancer, recurrent or metastatic breast cancer (if other regimens have failed), as well as Langerhans cell histiocytosis.

Dosage form: solution for injection

ATC: L01CA01

The drug is used to treat various types of cancer, including acute leukemias, lymphomas, breast cancer, lung cancer, sarcomas, Wilms' tumor, as well as idiopathic thrombocytopenic purpura.

Dosage form: solution for injection

ATC: L01CA02